Rennova Health's Labs Win Appeal in the Eleventh Circuit Court of Appeals in CIGNA Suit
WEST PALM BEACH, FL --(Marketwired - September 25, 2017) - Rennova Health,
Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a leader in
diagnostic and supportive software solutions for healthcare companies, announces that it received a favorable decision from the
Eleventh Circuit Court of Appeals reversing an earlier decision by the U.S. District Court.
Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC (the "Companies") filed suit against CIGNA Health in 2015 alleging
that CIGNA failed to pay claims for laboratory services the Companies provided to patients pursuant to CIGNA-issued and
CIGNA-administrated plans. In 2016, the U.S. District Court dismissed part of the Companies' claims for lack of standing. The
Companies appealed that decision to the Eleventh Circuit Court of Appeals, which recently reversed the district court's decision
and found that the Companies have standing to raise claims arising out of traditional insurance plans as well as self-funded
plans.
"This is an exciting development for us," said Seamus Lagan, Chief Executive Officer, "and allows us to push forward in our
pursuit of the total amount of our original claims."
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering
an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands
that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit
www.rennovahealth.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the
United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently,
you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate,"
"project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts,"
"potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking
statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected
results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with
the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking
statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to
release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any
change in events, conditions or circumstances on which any such statement is based, except as required by law.